3 Marijuana Stocks to Avoid at All Costs

CannTrust Holdings Inc. (TSX:TRST)(NYSE:CTST), Alcanna Inc (TSX:CLIQ), and Canopy Growth Corp (TSX:WEED)(NYSE:CGC) are showing red flags; therefore, you should avoid the stocks, even at rock-bottom prices.

| More on:
Powder of Cannabis (Drugs), Analysis of Cannabis in laboratory.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

The current state of the legal marijuana industry is messy, if not chaotic. If you’re one of the many hoping to make thousands of bucks on weed stocks, be careful which ones you pick. Some are not worth your money, so you’d better avoid them at all costs.

CannTrust (TSX:TRST)(NYSE:CTST), Alcanna (TSX:CLIQ), and Canopy Growth (TSX:WEED)(NYSE:CGC) are not the best choices. Don’t let the low prices lull into a false sense of security. The enormous gains you’re dreaming of might not come at all.

Dirty tricks

CannTrust was producing and selling “bad” weed. The atrocious part was that its top executives knew the company was violating Canada’s cannabis regulation laws. As of this writing, the stock is trading at $2.19, and it’s down 66.67% year to date.

Health Canada’s non-compliance report last July was telling. CannTrust was growing cannabis in five unlicensed rooms at its greenhouse facility in Pelham, Ontario, from October last year to May this year. The cultivation rooms had pending applications with Health Canada while the dirty antics were happening.

CannTrust’s problems will not end, as compliance issues against the company are mounting. One report mentions that a CannTrust employee bought seeds from the black market that found their way to the company’s growing facility. The scandal has completely ruined the company’s reputation.

Mixing the brew

Alcanna is not a pure-play marijuana stock. The company is a retailer of wines, beer, and spirits but is capitalizing on the marijuana hype. While Alcanna is a fixture in Canada’s retail liquor business, the stock has no gains to show in the last 16 months.

By entering the cannabis market and transforming liquor stores to cannabis shops, Alcanna is hoping to build a strong foundation for long-term growth and stock appreciation. It has nine retail cannabis stores at the moment and 20 more might open by the end of 2019.

The company can’t boast of profits in the last 12 months. You can’t be sure if alcohol and marijuana is the right mix to help the company re-establish its market foothold. In mid-May 2018, CLIQ was trading at $9.52. Today, it’s down by 38.1% to $5.89. If you don’t want to lose money, pick other weed stocks.

Shrinking giant

Shares of Canopy Growth are selling 48.64% cheaper today at $35.70 from almost $70 in late April. You might say this is an excellent buying opportunity. But if you know that the largest cannabis producer by market capitalization can lose $1 billion in a quarter, it’s a letdown.

Canopy Growth has better chances than CannTrust and Alcanna to succeed. However, you should be willing to wait longer to realize gains. The company is still headless and looking for a new leader to steer the ship.

The bright spot is the coming of Canada’s Cannabis 2.0 market. Expect Canopy Growth to be at the forefront of cannabis-infused beverages, vapes, and cannabis edibles, among others. Until then, the cannabis giant is still in a coma.

Heed the warning

For your pocket’s sake, heed the advice. CannTrust, Alcanna, and Canopy Growth are not good investment options in the cannabis space. Only one has the potential to redeem lost glory.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »